HOME >> MEDICINE >> NEWS
Prostate cancer research may be faster with PSA endpoints

A new study from Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia, who are members of the Southwest Oncology Group (SWOG), suggests that certain changes in prostate-specific antigen (PSA) levels may serve as surrogate endpoints for prostate cancer survival. Researchers looking to speed up the process of clinical trials have suggested that these biomarkers could be used to measure treatment efficacy.

Currently, the U.S. Food and Drug Administration accepts only survival as an endpoint of measure. Survival as a primary endpoint was used in phase III studies of novel chemotherapeutic drugs for men with androgen-independent prostate.

Daniel P. Petrylak, M.D., associate professor of medicine at Columbia University College of Physicians & Surgeons and director of the genitourinary oncology program at NewYork-Presbyterian/Columbia, together with his research team, retrospectively analyzed results of 551 men with prostate cancer treated in the Southwest Oncology Group Protocol S9916. By reviewing the clinical trial, it was noted that there were several different changes in PSA levels, which could possibly serve as surrogate endpoints for survival.

The authors observed that the risk of death, in men whose serum PSA levels declined by at least 30 percent in the first three months of treatment, was reduced more than 50 percent. Findings are published in the Journal of the National Cancer Institute (April 19, 2006 issue).

"The findings show that PSA levels can be a reliable endpoint measure of prostate cancer treatment efficacy," said Dr. Petrylak, lead investigator. "However, this and other candidate surrogate endpoints must be validated in independent clinical trials of men with prostate cancer."

This study is a follow-up to a landmark phase III trial published in the New England Journal of Medicine (Oct. 7, 2004), by the same Columbia University Medical Center and NewYork-Presbyterian Hos
'"/>

Contact: Elizabeth Streich
eas2125@columbia.edu
212-305-6535
Columbia University Medical Center
18-Apr-2006


Page: 1 2

Related medicine news :

1. Prostate cancer patients see high survival rates with seed implants
2. Prostate cancer treatment increases risk of diabetes and heart disease
3. Prostate treatment decisions based on perception more than fact
4. Prostate cancer test affected by demographic and lifestyle factors
5. Prostate cancer therapy - study suggests new molecular screening theory
6. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
7. Survival differences by race most apparent in advanced stages of breast cancer
8. Stomach cancer rate set to fall further 25 percent over next decade
9. MRI finds breast cancer before it becomes dangerous
10. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
11. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... The American ... (CMAC). Originally developed and launched by the Center for Case Management in 2000, ... management administrators, managers, supervisors and leaders. , “I created the CMAC credential ...
(Date:2/19/2019)... Mass. (PRWEB) , ... February 19, 2019 , ... ... the impact of weight stigma in pregnant and postpartum women, a team led ... during pregnancy and early postpartum often show increased depressive symptoms, greater weight gain ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, ... at the annual US Bioassay Conference of the BioPharmaceutical Emerging Best Practices ...
(Date:2/19/2019)... ... February 19, 2019 , ... Tap water ... based in The Villages FL proudly serving over 3,500 satisfied customers. I’m looking ... the greater Jacksonville area selling and installing our popular Water Filtration Systems," says ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... Clover Creek Cultivation LLC , a newly-licensed cannabis cultivation and manufacturing company ... and ethanol extraction, distillation, and ISO-7 product formulation, while Clover Creek is poised ...
Breaking Medicine News(10 mins):
(Date:2/22/2019)... ... February 22, 2019 , ... On Thursday, Feb. 14, Dutch Bros Coffee and its customers celebrated ... million meals for local food banks in seven states. , “To provide quality food for ... Bros. “Being a part of this special day is an honor.” , Dutch Bros donated ...
(Date:2/19/2019)... S.C. (PRWEB) , ... February 20, 2019 , ... ... Missing College Courses: Important Information That Is Nearly Never Covered in a University or ... each of his book’s 36 chapters is not covered in undergraduate courses of a ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... Job Syndrome by providing the scientific community with additional opportunities to further research ... as Chief Scientific Officer of the Foundation’s Scientific Advisory Board and the addition ...
Breaking Medicine Technology:
Cached News: